I agree. The Copaxone Markman hearing is a much better explanation of MNTA’s recent price action than the notion that someone outside the FDA knows something we don’t about Lovenox.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”